Teva Sees Adderall Supply Delays Continuing for 2-3 Months

 Teva Pharmaceutical Industries Ltd.will continue to have challenges supplying the popular attention-deficit/hyperactivity disorder drug Adderall for the next two to three months, a company spokesperson said.

The drug has been in short supply since at least August, an issue that started this summer with a labor shortage at Teva, which supplies more Adderall in the US than any other company. Teva sells both the branded and generic products, and demand for the drug is at an all-time high.

https://news.bloomberglaw.com/health-law-and-business/teva-expects-adderall-supply-delays-to-continue-for-2-3-months